Quarterly update
Watch the investment team recap this quarter.
(Note: Filmed in April 2024).
ABOUT THIS STRATEGY
We believe in the power of deep, fundamental research to identify life science companies trading at a significant discount to intrinsic value. We feel the quality of our team, the depth of our research and our disciplined long-term approach set us apart in pursuing superior risk-adjusted results for our clients.
INVESTMENT APPROACH
Health care expertise: Our domain experts have 95+ years of combined experience investing in the complex and dynamic health care sector. Our team of specialists, which include multiple Ph.D.’s, seek to understand both the science and the business of prospective investments.
Balanced approach: We diversify the portfolio across market capitalisations, geographies and the primary sub-sectors of health care, including investments in biotechnology, health care services, medical devices and pharmaceuticals.
Integrated risk management process: Security-level “Value at Risk” framework focuses attention on downside risks by limiting the position size of higher-risk stocks.
Featured Insight
Equity Perspectives
Quarterly insight from our equity teams to help clients navigate the markets and opportunities ahead.
